BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 18682290)

  • 1. The molecular regulation of Janus kinase (JAK) activation.
    Babon JJ; Lucet IS; Murphy JM; Nicola NA; Varghese LN
    Biochem J; 2014 Aug; 462(1):1-13. PubMed ID: 25057888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of phosphorylation near drug binding sites in the Protein Data Bank (PDB) and their effects.
    Smith KP; Gifford KM; Waitzman JS; Rice SE
    Proteins; 2015 Jan; 83(1):25-36. PubMed ID: 24833420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phosphotyrosine switch for cargo sequestration at clathrin-coated buds.
    Chakraborty S; Umasankar PK; Preston GM; Khandelwal P; Apodaca G; Watkins SC; Traub LM
    J Biol Chem; 2014 Jun; 289(25):17497-514. PubMed ID: 24798335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis.
    Cutolo M; Meroni M
    J Inflamm Res; 2013 Nov; 6():129-37. PubMed ID: 24453498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine 201 is required for constitutive activation of JAK2V617F and efficient induction of myeloproliferative disease in mice.
    Yan D; Hutchison RE; Mohi G
    Blood; 2012 Aug; 120(9):1888-98. PubMed ID: 22837531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Janus kinase 3: the controller and the controlled.
    Wu W; Sun XH
    Acta Biochim Biophys Sin (Shanghai); 2012 Mar; 44(3):187-96. PubMed ID: 22130498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of Y372 is critical for Jak2 tyrosine kinase activation.
    Sayyah J; Gnanasambandan K; Kamarajugadda S; Tsuda S; Caldwell-Busby J; Sayeski PP
    Cell Signal; 2011 Nov; 23(11):1806-15. PubMed ID: 21726629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies.
    Jatiani SS; Baker SJ; Silverman LR; Reddy EP
    Genes Cancer; 2010 Oct; 1(10):979-93. PubMed ID: 21442038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological interactions between hematopoietic stem cells and their niche revealed by mouse models of primary myelofibrosis.
    Varricchio L; Mancini A; Migliaccio AR
    Expert Rev Hematol; 2009 Jun; 2(3):315-334. PubMed ID: 20352017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK redux: a second look at the regulation and role of JAKs in the heart.
    Kurdi M; Booz GW
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1545-56. PubMed ID: 19717737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Jak2 function by phosphorylation of Tyr317 and Tyr637 during cytokine signaling.
    Robertson SA; Koleva RI; Argetsinger LS; Carter-Su C; Marto JA; Feener EP; Myers MG
    Mol Cell Biol; 2009 Jun; 29(12):3367-78. PubMed ID: 19364823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Janus kinases in immune cell signaling.
    Ghoreschi K; Laurence A; O'Shea JJ
    Immunol Rev; 2009 Mar; 228(1):273-87. PubMed ID: 19290934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation.
    Boyle K; Zhang JG; Nicholson SE; Trounson E; Babon JJ; McManus EJ; Nicola NA; Robb L
    Cell Signal; 2009 Mar; 21(3):394-404. PubMed ID: 19056487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative regulation of Jak2 by its auto-phosphorylation at tyrosine 913 via the Epo signaling pathway.
    Funakoshi-Tago M; Tago K; Kasahara T; Parganas E; Ihle JN
    Cell Signal; 2008 Nov; 20(11):1995-2001. PubMed ID: 18682290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Granulocyte-macrophage colony-stimulating factor and erythropoietin induce tyrosine phosphorylation and activation of JAK2].
    Ren H; Lu D
    Zhonghua Xue Ye Xue Za Zhi; 1997 Mar; 18(3):137-9. PubMed ID: 15622774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin induces sustained phosphorylation of STAT5 in primitive but not definitive erythrocytes generated from mouse embryonic stem cells.
    Tsuji-Takayama K; Otani T; Inoue T; Nakamura S; Motoda R; Kibata M; Orita K
    Exp Hematol; 2006 Oct; 34(10):1323-32. PubMed ID: 16982325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells--signals emanating from the erythropoietin receptor.
    Klingmüller U
    Eur J Biochem; 1997 Nov; 249(3):637-47. PubMed ID: 9395308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jak2: normal function and role in hematopoietic disorders.
    Ihle JN; Gilliland DG
    Curr Opin Genet Dev; 2007 Feb; 17(1):8-14. PubMed ID: 17208428
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.